The association of Aβ amyloid and composite cognitive measures in healthy older adults and MCI

Karra D. Harrington*, Yen Ying Lim, Kathryn A. Ellis, Carly Copolov, David Darby, Michael Weinborn, David Ames, Ralph N. Martins, Greg Savage, Cassandra Szoeke, Christopher Rowe, Victor L. Villemagne, Colin L. Masters, Paul Maruff

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    22 Citations (Scopus)

    Abstract

    Background: To date evidence of the relationship between cognition and Aβ amyloid during the early stages of Alzheimer's Disease (AD) has been inconsistent. This study aimed to describe the nature and magnitude of the relationship between Aβ amyloid and cognitive performance of individuals without dementia. Methods: Composite cognitive measures were developed from the Australian Imaging Biomarkers and Lifestyle study neuropsychological test battery using data from 768 healthy older adults and 133 adults with mild cognitive impairment (MCI). A subgroup of this sample (174 healthy, 53 MCI) underwent neuroimaging for Aβ amyloid. Results: Within the MCI group individuals with high Aβ amyloid showed selective impairment for memory compared with those with low Aβ amyloid; however, this difference was not evident in the healthy group. Conclusions: The current findings provide further evidence of the relationship between Aβ amyloid and cognition, with memory impairment being the primary symptom of the underlying disease during the prodromal phases of AD.

    Original languageEnglish
    Pages (from-to)1667-1677
    Number of pages11
    JournalInternational Psychogeriatrics
    Volume25
    Issue number10
    DOIs
    Publication statusPublished - Oct 2013

    Fingerprint

    Dive into the research topics of 'The association of Aβ amyloid and composite cognitive measures in healthy older adults and MCI'. Together they form a unique fingerprint.

    Cite this